CN118685347A - A method for extracting and separating high-purity exosomes - Google Patents
A method for extracting and separating high-purity exosomes Download PDFInfo
- Publication number
- CN118685347A CN118685347A CN202410838758.6A CN202410838758A CN118685347A CN 118685347 A CN118685347 A CN 118685347A CN 202410838758 A CN202410838758 A CN 202410838758A CN 118685347 A CN118685347 A CN 118685347A
- Authority
- CN
- China
- Prior art keywords
- exosomes
- supernatant
- exosome
- purity
- exchange chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 36
- 239000000945 filler Substances 0.000 claims abstract description 19
- 239000006228 supernatant Substances 0.000 claims abstract description 17
- 239000012535 impurity Substances 0.000 claims abstract description 13
- 239000002245 particle Substances 0.000 claims abstract description 13
- 239000000706 filtrate Substances 0.000 claims abstract description 11
- 238000004255 ion exchange chromatography Methods 0.000 claims abstract description 11
- 239000003480 eluent Substances 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 238000012856 packing Methods 0.000 claims abstract 5
- 239000000243 solution Substances 0.000 claims description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 238000000746 purification Methods 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 7
- 239000012148 binding buffer Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical group Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- 239000007995 HEPES buffer Substances 0.000 claims description 4
- 239000007983 Tris buffer Substances 0.000 claims description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 4
- 239000012930 cell culture fluid Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- 238000004271 weak anion exchange chromatography Methods 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 238000001493 electron microscopy Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 5
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 238000001542 size-exclusion chromatography Methods 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000710 polymer precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000005199 ultracentrifugation Methods 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012792 core layer Substances 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000035992 intercellular communication Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 201000011682 nervous system cancer Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
技术领域Technical Field
本发明属于外泌体分离提取技术领域,具体涉及一种提取分离高纯度外泌体的方法。The present invention belongs to the technical field of exosome separation and extraction, and specifically relates to a method for extracting and separating high-purity exosomes.
背景技术Background Art
外泌体是由细胞分泌的具有膜结构的囊泡,直径在40~160nm之间,内含多种核酸、蛋白质、脂质等成分,在细胞间的通讯发挥重要作用。外泌体具有良好的耐受性和生物相容性、较低免疫原性、可以穿越天然屏障、可进行工程化改造等诸多优势,目前已作为递送载体被广泛应用在心血管疾病、肾损伤、免疫疾病、神经系统疾病和癌症等多种疾病的治疗研究中。Exosomes are membrane-structured vesicles secreted by cells, with a diameter of 40 to 160 nm. They contain a variety of nucleic acids, proteins, lipids and other components, and play an important role in intercellular communication. Exosomes have many advantages, such as good tolerance and biocompatibility, low immunogenicity, the ability to cross natural barriers, and the ability to be engineered. Currently, they have been widely used as delivery carriers in the treatment of cardiovascular diseases, kidney damage, immune diseases, nervous system diseases, cancer and other diseases.
外泌体的分离提取方法包括超速离心、超滤和尺寸排阻色谱法、聚合物沉淀、免疫亲和层析等。目前,超速离心是外泌体分离的“金标准”,但这个方法通常需要超过100000g的离心力,而且分离操作复杂且周期长。超滤和尺寸排阻色谱法都是根据外泌体尺寸进行分离的方法。超滤是将样品通过具有不同孔径的膜过滤器,根据颗粒的大小和分子量进行分离。尺寸排阻色谱也是根据颗粒的大小进行分离的,较大的颗粒先离开色谱柱被分离出来,而较小的颗粒较晚离开因此被收集。聚合物沉淀是通过添加聚乙二醇,将外泌体在溶液中形成沉淀,再通过1500g低速离心,使外泌体得以分离,该方法适用于大量样本,但所得外泌体纯度较低。免疫亲和层析是根据外泌体表面特有的抗原分子,使其与抗体相结合而被分离出来,该方法特异性强但产量较低,且难以从样品中完全除去抗体。Methods for the separation and extraction of exosomes include ultracentrifugation, ultrafiltration and size exclusion chromatography, polymer precipitation, immunoaffinity chromatography, etc. At present, ultracentrifugation is the "gold standard" for the separation of exosomes, but this method usually requires a centrifugal force of more than 100,000g, and the separation operation is complicated and the cycle is long. Ultrafiltration and size exclusion chromatography are both methods for separation based on the size of exosomes. Ultrafiltration is to pass the sample through a membrane filter with different pore sizes and separate it according to the size and molecular weight of the particles. Size exclusion chromatography is also separated according to the size of the particles. Larger particles leave the chromatographic column first and are separated, while smaller particles leave later and are therefore collected. Polymer precipitation is to add polyethylene glycol to form a precipitate in the solution, and then centrifuge at 1500g at a low speed to separate the exosomes. This method is suitable for a large number of samples, but the purity of the resulting exosomes is low. Immunoaffinity chromatography is based on the antigen molecules unique to the surface of exosomes, which are separated by binding to antibodies. This method has strong specificity but low yield, and it is difficult to completely remove antibodies from the sample.
近来,有研究表明,利用电荷原理通过离子交换层析填料可以提取外泌体,此方法可使用简单的离心机设备进行外泌体提取,然而,发明人在研究时发现,通过离子交换层析填料虽然可以提取到细胞上清、尿液中的外泌体,但是电镜结果显示所得外泌体背景中存在大量杂质,这对外泌体的实际使用显然是不利的。Recently, studies have shown that exosomes can be extracted through ion exchange chromatography fillers using the principle of charge. This method can use a simple centrifuge device to extract exosomes. However, the inventors found during their research that although exosomes in cell supernatant and urine can be extracted through ion exchange chromatography fillers, electron microscopy results show that there are a large number of impurities in the background of the obtained exosomes, which is obviously not conducive to the actual use of exosomes.
发明内容Summary of the invention
针对通过离子交换填料提取的外泌体中存在大量杂质的问题,本发明提供了一种提取纯化外泌体的方法,该方法简单且有效。In view of the problem that a large amount of impurities exist in exosomes extracted by ion exchange fillers, the present invention provides a method for extracting and purifying exosomes, which is simple and effective.
本发明的技术方案具体如下所示:The technical solution of the present invention is specifically as follows:
一种提取分离高纯度外泌体的方法,包括以下步骤:A method for extracting and separating high-purity exosomes, comprising the following steps:
S1、取样品依次经过离心、过滤以得到无大颗粒杂质的上清;S1. Centrifuge and filter the sample to obtain a supernatant without large particles;
S2、用离子交换层析填料吸附上清中的外泌体,再用洗脱液进行洗脱;S2, adsorbing the exosomes in the supernatant with ion exchange chromatography filler, and then eluting with eluent;
S3、将所得外泌体溶液加入装填MixQ700S填料的离心柱中,离心所得滤过液即为高纯度外泌体溶液。S3. Add the obtained exosome solution into a centrifugal column filled with MixQ700S filler, and the filtrate obtained by centrifugation is a high-purity exosome solution.
在本发明方法中,步骤S1中的样品具体为细胞培养液、尿液等生物体液。发明人对经过离子交换层析填料提取的外泌体进行鉴定分析后,发现电镜显示外泌体背景中的杂质多呈现为晶体小颗粒,进一步分析发现其包含盐粒子及其他非外泌体蛋白;发明人通过大量试验探索,发现仅利用装填MixQ700S填料的离心柱通过简单低速离心即可去除有效外泌体中的杂质,且鉴定所得电镜图背景干净。MixQ700S为一种复合模式填料,其中填料粒径为70um,核壳结构微球,壳层为中性亲水层,可阻止700KD以上的蛋白进入内部,核层为阴离子交换和疏水作用功能层,常用来分离纯化蛋白。In the method of the present invention, the sample in step S1 is specifically a biological fluid such as cell culture fluid and urine. After the inventors identified and analyzed the exosomes extracted by ion exchange chromatography fillers, they found that the impurities in the background of the exosomes were mostly small crystalline particles under electron microscopy. Further analysis found that it contained salt particles and other non-exosomal proteins. Through a large number of experimental explorations, the inventors found that the impurities in the effective exosomes can be removed by simple low-speed centrifugation using a centrifugal column filled with MixQ700S fillers, and the background of the electron microscope image obtained by identification is clean. MixQ700S is a composite mode filler, in which the filler particle size is 70um, a core-shell structure microsphere, the shell layer is a neutral hydrophilic layer, which can prevent proteins above 700KD from entering the interior, and the core layer is an anion exchange and hydrophobic interaction functional layer, which is often used to separate and purify proteins.
优选地,在上述方法中,步骤S1中的离心条件为1500-3000g离心10-20min,过滤则是采用0.22μm孔径滤膜对离心上清液进行过滤。本发明方法先通过离心去除样品中的大颗粒杂质,再通过过滤除去非外泌体大囊泡和大部分杂蛋白;样品经过这些前处理,就可以得到无大颗粒杂质的上清,利于后续吸附、洗脱。Preferably, in the above method, the centrifugation condition in step S1 is 1500-3000g for 10-20min, and the filtration is to filter the centrifugal supernatant with a 0.22μm pore size filter membrane. The method of the present invention first removes large particle impurities in the sample by centrifugation, and then removes non-exosome large vesicles and most of the miscellaneous proteins by filtration; after these pre-treatments, the sample can obtain a supernatant without large particle impurities, which is conducive to subsequent adsorption and elution.
优选地,在上述方法中,步骤S2具体为:将离子交换层析填料、上清于结合缓冲液中孵育后,离心并将沉淀转移至纯化柱中,用洗涤液进行洗涤,再用洗脱液进行洗脱。Preferably, in the above method, step S2 specifically comprises: incubating the ion exchange chromatography filler and the supernatant in a binding buffer, centrifuging and transferring the precipitate to a purification column, washing with a washing solution, and then eluting with an eluent.
优选地,在上述方法中,步骤S2中离子交换层析填料为弱阴离子交换层析填料,其中弱阴离子交换剂包括二乙胺基乙基。Preferably, in the above method, the ion exchange chromatography filler in step S2 is a weak anion exchange chromatography filler, wherein the weak anion exchanger comprises diethylaminoethyl.
更优选地,在上述方法的步骤S2中,结合缓冲液为200-500mM Tris-HCl缓冲液(pH7.0-8.0),洗涤液为50-200mM Tris、10-150mM NaCl(pH 7.2-8.0),洗脱液为50-100mMHEPES、100-500mM NaCl。More preferably, in step S2 of the above method, the binding buffer is 200-500 mM Tris-HCl buffer (pH 7.0-8.0), the washing solution is 50-200 mM Tris, 10-150 mM NaCl (pH 7.2-8.0), and the elution solution is 50-100 mM HEPES, 100-500 mM NaCl.
优选地,在上述方法中,步骤S3的离心条件为:300-1000g离心30-90s。Preferably, in the above method, the centrifugation condition of step S3 is: 300-1000g centrifugation for 30-90s.
与现有技术相比,本发明的有益效果为:Compared with the prior art, the present invention has the following beneficial effects:
针对利用离子交换层析填料吸附作用,提取分离外泌体过程中的杂质问题,本发明创新地引入了自填装MixQ700S填料的离心柱,且通过简单的离心操作即可达到完全去除杂质的效果。In order to solve the problem of impurities in the process of extracting and separating exosomes by adsorption of ion exchange chromatography fillers, the present invention innovatively introduces a centrifugal column with self-filled MixQ700S filler, and the effect of completely removing impurities can be achieved through a simple centrifugation operation.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为实施例1提取分离的外泌体的TEM电镜图。FIG1 is a TEM electron microscope image of the exosomes extracted and separated in Example 1.
图2为对比例1提取分离的外泌体的TEM电镜图。Figure 2 is a TEM electron microscope image of the exosomes extracted and separated in Comparative Example 1.
具体实施方式DETAILED DESCRIPTION
下面将结合实施例和附图对本发明的技术方案进行清楚、完整地描述。应当理解的是,此处所描述的具体实施方式仅用于说明和解释本发明,并不用于限制本发明。The technical solution of the present invention will be described clearly and completely below in conjunction with the embodiments and drawings. It should be understood that the specific implementation methods described herein are only used to illustrate and explain the present invention and are not used to limit the present invention.
除非另有定义,本文所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本发明的说明书和权利要求书中的术语“包括”以及它的任何变形,意图在于覆盖不排他的包含。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. The term "comprises" and any variation thereof in the specification and claims of the present invention are intended to cover non-exclusive inclusions.
以下实施例中未注明具体技术或条件的,均按照本领域内的文献所描述的技术或条件或按照产品说明书进行;所用试剂或仪器未注明生产厂商者,均为可以通过市购获得的常规产品。If no specific techniques or conditions are specified in the following examples, all of them are carried out according to the techniques or conditions described in the literature in the field or according to the product instructions; if the manufacturer of the reagents or instruments is not specified, they are all conventional products that can be obtained commercially.
实施例1Example 1
本例以HEK293T细胞培养液为例,按照本发明方法进行外泌体的提取和鉴定,具体包括以下步骤:In this example, HEK293T cell culture fluid is used as an example, and the extraction and identification of exosomes are performed according to the method of the present invention, which specifically includes the following steps:
(1)取10ml细胞培养液在4℃、1500g离心10min,去除悬浮细胞和细胞碎片,所得上清液过0.22μm孔径滤膜,去除较大的微囊泡,吸取5ml滤液于10ml离心管中。(1) Take 10 ml of cell culture medium and centrifuge it at 4°C and 1500 g for 10 min to remove suspended cells and cell debris. Pass the resulting supernatant through a 0.22 μm pore size filter to remove larger microvesicles. Pipette 5 ml of the filtrate into a 10 ml centrifuge tube.
(2)移液器吸取500μl结合缓冲液(200mM Tris-HCl缓冲液,pH 8.0)加入到步骤(1)中装有滤液的离心管中,盖紧盖子,颠倒混匀。(2) Use a pipette to add 500 μl of binding buffer (200 mM Tris-HCl buffer, pH 8.0) into the centrifuge tube containing the filtrate in step (1), close the lid, and invert to mix.
(3)吸取300μl DEAE树脂溶液加入到步骤(2)所得离心管中,盖紧盖子,在室温下连续颠倒混匀,孵育15min,1500g离心2min,轻轻将离心管从离心机中取出,用移液器取500μl上清液(不要弃掉),小心倒掉剩余上清液,用移液器中的液体(500μl)轻轻吹起树脂,全部转移至纯化柱中(已放入收集管),静置2min,2000g室温离心2min,吸取500μl的洗涤液(pH 8.0, 50mM Tris, 10mM NaCl)加入到纯化柱中,静止5min,2000g室温离心2min,将滤液及收集管一并弃掉。(3) Pipette 300 μl of DEAE resin solution into the centrifuge tube obtained in step (2), cover the lid tightly, mix by continuous inversion at room temperature, incubate for 15 min, centrifuge at 1500 g for 2 min, gently remove the centrifuge tube from the centrifuge, take 500 μl of supernatant with a pipette (do not discard), carefully pour out the remaining supernatant, gently blow up the resin with the liquid in the pipette (500 μl), transfer all of it to the purification column (which has been placed in the collection tube), let it stand for 2 min, centrifuge at 2000 g for 2 min at room temperature, pipette 500 μl of washing solution (pH 8.0, 50 mM Tris, 10 mM NaCl) and add it to the purification column, let it stand for 5 min, centrifuge at 2000 g for 2 min at room temperature, and discard the filtrate and collection tube.
(4)将纯化柱转移至低吸附蛋白的1.5ml离心管中,加入200μl的洗脱液(pH 7.2,50mM HEPES, 100mM NaCl),孵育5min,350g室温离心2min,将离心后的滤过液重新转移至纯化柱中,孵育5min,2500g室温离心3min,离心管中所得液体即为浓缩后的外泌体溶液。(4) Transfer the purification column to a 1.5 ml centrifuge tube with low protein adsorption, add 200 μl of elution buffer (pH 7.2, 50 mM HEPES, 100 mM NaCl), incubate for 5 min, centrifuge at 350 g for 2 min at room temperature, transfer the filtrate back to the purification column, incubate for 5 min, and centrifuge at 2500 g for 3 min at room temperature. The liquid obtained in the centrifuge tube is the concentrated exosome solution.
(5)将浓缩后的外泌体溶液加入预装MixQ700S填料的离心小柱中,300g离心90s,滤过液即为去除杂质的外泌体溶液。(5) Add the concentrated exosome solution to a centrifugal column pre-filled with MixQ700S filler and centrifuge at 300 g for 90 seconds. The filtrate is the exosome solution with impurities removed.
对步骤(5)所得外泌体溶液进行电镜检测,结果如图1所示:电镜照片背景干净,不存在明显杂质,且外泌体较多、形态完整。The exosome solution obtained in step (5) was subjected to electron microscopy, and the results are shown in Figure 1: the electron microscopy photo shows a clean background, no obvious impurities, and a large number of exosomes with complete morphology.
对比例1Comparative Example 1
本例所用样品同实施例1一致,并通过以下步骤提取其外泌体:The samples used in this example are the same as those in Example 1, and exosomes are extracted by the following steps:
(1)取10ml细胞培养液在4℃、1500g离心10min,去除悬浮细胞和细胞碎片,所得上清液过0.22μm孔径滤膜,去除较大的微囊泡,吸取5ml滤液于10ml离心管中。(1) Take 10 ml of cell culture medium and centrifuge it at 4°C and 1500 g for 10 min to remove suspended cells and cell debris. Pass the resulting supernatant through a 0.22 μm pore size filter to remove larger microvesicles. Pipette 5 ml of the filtrate into a 10 ml centrifuge tube.
(2)移液器吸取500μl结合缓冲液(200mM Tris-HCl缓冲液,pH8.0)加入到步骤(1)中装有滤液的离心管中,盖紧盖子,颠倒混匀。(2) Pipette 500 μl of binding buffer (200 mM Tris-HCl buffer, pH 8.0) into the centrifuge tube containing the filtrate in step (1), close the lid, and invert to mix.
(3)吸取300μl DEAE树脂加入到步骤(2)所得离心管中,盖紧盖子,在室温下连续颠倒混匀,孵育15min,1500g离心2min,轻轻将离心管从离心机中取出,用移液器取500μl上清液(不要弃掉),小心倒掉剩余上清液,用移液器中的液体(500μl)轻轻吹起树脂,全部转移至纯化柱中(已放入收集管),静置2min,2000g室温离心2min,吸取500μl的洗涤液(pH8.0, 50mM Tris, 10mM NaCl)加入到纯化柱中,静止5min,2000g室温离心2min,将滤液及收集管一并弃掉。(3) Pipette 300 μl of DEAE resin into the centrifuge tube obtained in step (2), cover the lid tightly, mix by continuous inversion at room temperature, incubate for 15 min, centrifuge at 1500 g for 2 min, gently remove the centrifuge tube from the centrifuge, use a pipette to take 500 μl of supernatant (do not discard), carefully pour out the remaining supernatant, use the liquid in the pipette (500 μl) to gently blow up the resin, transfer all of it into the purification column (which has been placed in the collection tube), let it stand for 2 min, centrifuge at 2000 g for 2 min at room temperature, pipette 500 μl of washing solution (pH 8.0, 50 mM Tris, 10 mM NaCl) and add it to the purification column, let it stand for 5 min, centrifuge at 2000 g for 2 min at room temperature, and discard the filtrate and collection tube.
(4)将纯化柱转移至低吸附蛋白的1.5ml离心管中,加入200μl的洗脱液(pH7.2,50mM HEPES, 100mM NaCl),孵育5min,350g室温离心2min,将洗脱液重新转移至纯化柱中,孵育5min,2500g室温离心3min,离心管中所得液体即为外泌体溶液。(4) Transfer the purification column to a 1.5 ml centrifuge tube with low protein adsorption, add 200 μl of elution buffer (pH 7.2, 50 mM HEPES, 100 mM NaCl), incubate for 5 min, centrifuge at 350 g for 2 min at room temperature, transfer the eluate back to the purification column, incubate for 5 min, and centrifuge at 2500 g for 3 min at room temperature. The liquid obtained in the centrifuge tube is the exosome solution.
对步骤(4)所得外泌体溶液进行电镜检测,结果如图2所示:本例所得外泌体的电镜照片背景不干净,呈现很多成片晶体小颗粒。The exosome solution obtained in step (4) was subjected to electron microscopy, and the results are shown in FIG2 : The electron microscopy photograph of the exosomes obtained in this example showed an unclean background and many small crystalline particles.
综上所述,本发明通过引入自填装MixQ700S填料的离心柱,能够克服现有方法的缺陷,获取高纯度外泌体的同时,保证了外泌体的完整性好,可见本发明方法能够获取质量高的外泌体,对外泌体的下游应用具有重要意义。In summary, the present invention can overcome the defects of the existing method by introducing a centrifugal column with self-filled MixQ700S filler, obtain high-purity exosomes, and ensure the good integrity of the exosomes. It can be seen that the method of the present invention can obtain high-quality exosomes, which is of great significance to the downstream applications of exosomes.
需要说明的是,以上实施例仅是本发明一部分实施例而不是全部的实施例,仅用以说明本发明的技术方案而非限制;基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动条件下所获得的所有其它实施例,都属于本发明保护的范围。It should be noted that the above embodiments are only part of the embodiments of the present invention rather than all the embodiments, and are only used to illustrate the technical solution of the present invention rather than to limit it. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410838758.6A CN118685347A (en) | 2024-06-26 | 2024-06-26 | A method for extracting and separating high-purity exosomes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410838758.6A CN118685347A (en) | 2024-06-26 | 2024-06-26 | A method for extracting and separating high-purity exosomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118685347A true CN118685347A (en) | 2024-09-24 |
Family
ID=92772432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410838758.6A Pending CN118685347A (en) | 2024-06-26 | 2024-06-26 | A method for extracting and separating high-purity exosomes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118685347A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119391627A (en) * | 2024-12-04 | 2025-02-07 | 美尔健(深圳)生物科技有限公司 | A preparation method and application of sheep-derived amniotic fluid exosomes |
-
2024
- 2024-06-26 CN CN202410838758.6A patent/CN118685347A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119391627A (en) * | 2024-12-04 | 2025-02-07 | 美尔健(深圳)生物科技有限公司 | A preparation method and application of sheep-derived amniotic fluid exosomes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5783686A (en) | Method for purifying nucleic acids from heterogenous mixtures | |
| CN113444682A (en) | Exosome separation and purification method | |
| CA2929268C (en) | Methods for extracellular vesicle isolation and selective removal | |
| US20090043087A1 (en) | DNA purification and recovery from high particulate and solids samples | |
| CN110540961B (en) | Annexin V-FITC exosome capture affinity magnetic bead, preparation method thereof and method for extracting exosome by using same | |
| CN113101737B (en) | Affinity tangential flow filtration system, construction method thereof, exosome extraction method and application | |
| CN112048462B (en) | Extracellular vesicle separation and enrichment method based on anionic polymer modified matrix | |
| CN115449505A (en) | Purification method for separating exosome and exosome kit | |
| CN114471163B (en) | Ultrafiltration device and method for secondary two-stage tangential flow separation, purification and concentration of exosomes | |
| WO2024140378A1 (en) | Scale extraction method for exosomes in fresh milk | |
| CN113249302A (en) | Efficient exosome separation and purification method | |
| CN112831457A (en) | Method for separating and concentrating exosome | |
| CN112813027B (en) | Method for separating exosomes in urine | |
| CN114397388A (en) | Urine exosome extraction kit based on combination of PEG precipitation method and SEC column method and application | |
| CN115948351B (en) | Method for separating and purifying CVB1 | |
| CN118440893A (en) | Preparation method of high-purity stem cell exosome | |
| CN118620824A (en) | Camel milk-derived exosomes and separation and purification method thereof | |
| CN118562727A (en) | Method for purifying exosomes and exosome quality control method | |
| CN112574950A (en) | Method for extracting cell exosomes | |
| CN117088964B (en) | Animal fibronectin co-production method | |
| CN121294312A (en) | A method for extracting and purifying exosomes | |
| CN118240745A (en) | A method for extracting and preparing exosomes | |
| CN119565380A (en) | Small-scale exosome separation and purification method and separation and purification kit | |
| CN121022716A (en) | Purification method | |
| CN115354024A (en) | Blood sample exosome extraction kit based on combination of protease treatment, SEC (SEC-activated charcoal) column and membrane filtration technology and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |